GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are among the most effective tools for keeping prediabetes from progressing to type 2 diabetes. In trials, a significant share of participants who started prediabetic reverted to normal A1C levels — driven by weight loss of 15–21% on average. They are not FDA-approved for prediabetes specifically, but are often prescribed under the obesity indication or off-label.
Prediabetes is one of those diagnoses that sounds gentler than it is. The word itself has "pre" in front of it, which makes it easy to treat as a warning light rather than a real event. According to the CDC, roughly one in three American adults has prediabetes, and a meaningful percentage of them will go on to develop full type 2 diabetes within five years if nothing changes.
If your doctor told you your A1C is creeping up, or you saw it on a routine lab panel and started reading, you have probably run into the conversation about GLP-1 medications. Ozempic is the most-Googled name in the category, even though the version approved for weight loss is actually called Wegovy, and even though there are newer medications in the same family like tirzepatide.
This article walks through what GLP-1 medications actually do, what the evidence looks like specifically for prediabetes, what realistic results tend to look like, and how to think about whether it makes sense for you. If you are ready to talk to a clinician, the Maro intake takes about 5 minutes.
What prediabetes actually means
Prediabetes is diagnosed when blood sugar is higher than it should be but not yet in the diabetes range. Usually this is picked up through a hemoglobin A1C test, which reflects average blood sugar over about three months. An A1C between 5.7 and 6.4 percent is considered prediabetes. Above that is diabetes.
What is happening under the hood is that insulin — the hormone that moves sugar out of the bloodstream and into cells — is not working as well as it used to. Your cells are becoming less responsive to it, so your pancreas has to produce more insulin to get the same effect. For a while, the body compensates. Eventually the pancreas cannot keep up, and blood sugar starts climbing into the diabetes range.
The time you spend in prediabetes is the window where reversal is still very much on the table. Lifestyle programs, weight loss, exercise, and in recent years GLP-1 medications can all push insulin sensitivity back toward normal and drop the A1C into a safer range.
How GLP-1 medications work
GLP-1 stands for glucagon-like peptide 1. It is a hormone your gut naturally releases after you eat. It does a few useful things at once. It signals the pancreas to release insulin when blood sugar is actually rising. It slows the rate that your stomach empties, so meals hit the bloodstream more gradually. And it signals the brain that you are satisfied, which reduces appetite between meals.
GLP-1 medications like semaglutide and tirzepatide mimic this hormone at a higher dose and a longer duration than your body produces naturally. Weekly injections keep the effect steady. The result in most patients is lower post-meal blood sugar spikes, reduced appetite, steady weight loss, and over time, better insulin sensitivity.
The cleaner way to think about it is that these medications do not fight biology. They amplify a signal your body already uses to regulate blood sugar and appetite, just more consistently than your own system has been doing lately.
What the evidence says for prediabetes
Most of the large trials on semaglutide and tirzepatide were run in populations with type 2 diabetes or with obesity, rather than in prediabetes specifically. That said, the prediabetes data is strong for a few reasons.
First, in the obesity trials, a significant share of participants were in the prediabetic range at baseline. The STEP 1 trial on semaglutide showed a large portion of people who started prediabetic reverted to normal A1C levels over 68 weeks of treatment. In the SURMOUNT-1 trial on tirzepatide, similar patterns showed up, with even higher rates of reversion because the weight loss was greater.
Second, weight loss is the single biggest driver of prediabetes reversal in general. The landmark Diabetes Prevention Program study showed that losing about seven percent of body weight through lifestyle changes cut the risk of progressing to diabetes by 58%. GLP-1 medications produce weight loss at that level or well beyond it in most patients.
Third, GLP-1s have direct effects on blood sugar regulation that are independent of weight loss. Even before the scale moves significantly, the medication is already improving how your body handles glucose after meals.
What realistic results look like
A few numbers worth knowing, based on what the trials and real-world data show.
Weight loss. On semaglutide at the weight-loss dose, average weight loss at around 68 weeks is roughly 15% of body weight. On tirzepatide, it is around 20–21% at the higher doses. Individual results vary widely — some men lose significantly more, some less. Genetics, diet, activity, and consistency all move the number.
A1C change. Men who start in the prediabetic range and lose meaningful weight typically see their A1C drop back into the normal range. This is one of the most consistent findings across studies. It does not happen overnight. A1C reflects three months of blood sugar, so the real change shows up around months four to six.
Appetite. Most men describe a dramatic shift in how they relate to food within a few weeks. The constant food noise quiets down. Portions that used to feel normal feel like too much. This is one of the biggest reasons the weight loss is sustainable — it is not willpower, it is a different hunger signal.
Timing. The first four weeks are typically about dose titration, meaning you start low to let your body adjust. Weight loss during that stretch is often modest. The real momentum tends to kick in around month two through six.
Side effects, honestly
Most side effects with GLP-1 medications are gastrointestinal and show up most during dose increases. Nausea is the most common, affecting around a third of people at some point in clinical trials. Others include constipation, occasional diarrhea, reflux, and a generally sluggish feeling in the gut. These usually settle within a couple of weeks after each dose change.
Less common but worth knowing: pancreatitis is a rare but real risk, gallbladder issues show up at higher rates in people losing weight rapidly, and there is a box warning about thyroid tumors based on rodent studies. That warning is why GLP-1s are generally not prescribed for anyone with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2.
For most men, the practical issue is managing the GI stuff during the first month or two. Smaller meals, more protein, less fried food, and more water help. If side effects are severe, dose increases can be slowed down rather than pushed on schedule.
What pairs well with it
GLP-1 medications work best when the rest of the picture is moving with them. A few things matter more than the rest.
Protein intake. When you are eating less overall, the composition of what you do eat matters more. Most men should aim for roughly 0.7 to 1 gram of protein per pound of goal body weight per day. This protects muscle mass during weight loss, which is not automatic on GLP-1s.
Resistance training. Same reason. Rapid weight loss without strength training leads to losing a meaningful portion of lean mass along with fat. Two or three strength sessions a week is enough to preserve most of it.
Steady walking. Not fancy cardio. Just daily walking. It helps insulin sensitivity directly and is one of the easiest things to sustain through a year of treatment.
Sleep. Poor sleep wrecks insulin sensitivity and makes weight loss significantly harder. The medication is not going to fully overcome chronic sleep deprivation. Fix what you can here.
How long should you stay on it
This is one of the most common questions and one of the most honest ones to answer. Obesity and prediabetes are chronic conditions. The medication works while you are on it. For most men who stop abruptly after significant weight loss, the hunger signal returns, weight comes back, and the metabolic gains reverse.
That does not mean everyone is on it forever. Some men stay on a lower maintenance dose after hitting their goal. Some taper off gradually while locking in lifestyle changes that can sustain the result. Some cycle through it during periods when they need it. The right answer is a clinical conversation based on where you land.
The one answer that usually does not work is treating it as a three-month challenge and then stopping cold. That is when regain tends to happen most dramatically.
Is this right for you
The honest filter is something like this. If your A1C is in the prediabetic range, you have weight to lose, lifestyle changes have been hard to stick to, and there is no contraindication, GLP-1 treatment is worth a real conversation. If your A1C is borderline and you have never actually given a consistent diet and exercise effort a try, starting there first is reasonable and often effective.
At Maro, the intake is straightforward. Licensed physicians review your health history, labs, and symptoms, determine if GLP-1 treatment is appropriate for you, and if so, ship it to your door. Most of the process happens online without a scheduled appointment — a few states require a brief live visit, and we'll tell you if yours is one during intake.
Start Your VisitFrequently asked questions
Is Ozempic approved for prediabetes?
Not specifically. Ozempic is FDA-approved for type 2 diabetes, and the same active ingredient at a higher dose (Wegovy) is approved for obesity. Tirzepatide has similar approvals. Use in prediabetes is typically via the obesity indication if BMI qualifies, or off-label with clinician judgment.
How fast will my A1C drop?
A1C reflects about three months of average blood sugar, so you will not see a meaningful change before month three, and the clearest reading is usually around month six. Most men who respond well see A1C drop back into normal range over that window.
Do I need labs before starting?
Yes. A baseline A1C, basic metabolic panel, and sometimes lipids and thyroid labs are standard before starting. They help set a baseline and screen for anything that would change the decision.
What is the difference between semaglutide and tirzepatide?
Semaglutide acts on one receptor (GLP-1). Tirzepatide acts on two (GLP-1 and GIP), which tends to drive more weight loss on average but can also produce more GI side effects. Both reduce A1C well. The right choice depends on goals, tolerance, and cost.
Will I gain the weight back if I stop?
For most men, some regain happens if the medication is stopped without a strong maintenance plan in place. That is not a failure of the medication — it reflects the fact that obesity is chronic. The decision to continue, taper, or stop should be made with a clinician based on your situation.
Get Maro's men's health reads in your inbox
One email a week. Clear takes on what works and what does not. No spam.
SubscribeKeep reading
How GLP-1 medications fit into prediabetes, what kind of results men usually see, and how to think about timing and whether it makes sense for you.
Read More